Skip to main content
. Author manuscript; available in PMC: 2012 Jan 1.
Published in final edited form as: Ann Epidemiol. 2011 Jan;21(1):34–41. doi: 10.1016/j.annepidem.2010.10.007

Table 1.

Characteristics of the Combined Cohort of Persons with Diabetes Adjusted for Age and Study, Mean (standard error) or Percent, and p-value for Black vs White

Women Men

Black (N=495) White (N=618) Black (N=340) White (N=504)
Age (yrs) 59 (0.5) (<0.0001) 62 (0.4) 60 (0.6) (0.02) 62 (0.4)

Study, N (%)
  DHS 244 (49) 441 (71) 139 (41) 314 (62)
  MESA 169 (34) 63 (10) 163 (48) 95 (19)
  FHS 82 (17) (<0.0001) 114 (18) 38 (11) (<0.0001) 95 (19)

Duration of diabetes (yrs) 8.6 (0.4) (0.002) 6.9 (0.4) 8.3 (0.5) (0.01) 7.0 (0.4)

HbA1c (%) * 7.9 (0.1) (0.0003) 7.4 (0.1) 7.9 (0.1) (<0.0001) 7.2 (0.1)

Currently treated for diabetes (%) 85 (<0.0001) 86 79 (<0.0001) 82

LDL (mg/dL) 112.8 (1.6) (0.06) 108.3 (1.5) 106.6 (2.1) (0.03) 101.2 (1.5)

HDL (mg/dL) 53.3 (0.7) (<0.0001) 47.5 (0.6) 44.8 (0.7) (<0.0001) 39.4 (0.5)

Triglycerides (mg/dL) 120.1 (5.3) (<0.0001) 203.7 (6.1) 123.6 (6.9) (<0.0001) 189.5 (7.7)

BMI (kg/m2) 35.1 (0.3) (0.0001) 33.3 (0.3) 31.1 (0.3) (0.41) 31.5 (0.3)

CRP (mg/L) 9.7 (0.8) (0.001) 6.4 (0.5) 5.7 (0.5) (0.0003) 3.7 (0.4)

Current smoking (%) 16 (<0.0001) 13 21 (0.004) 18

Past smoking (%) 29 (0.001) 28 47 (<0.0001) 52

Pack-years 7.8 (0.8) (0.005) 10.7 (1.0) 16.0 (1.2) (<0.0001) 25.2 (1.4)

Hypertension (%) 80 (<0.0001) 86 74 (<0.0001) 77

Lipid-lowering medication (%) 39 (<0.0001) 44 35 (<0.0001) 41
*

Sample size reduced: HbA1c not available for FHS.